Max Scherer

2.7k total citations
76 papers, 2.1k citations indexed

About

Max Scherer is a scholar working on Physiology, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Max Scherer has authored 76 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Physiology, 29 papers in Molecular Biology and 22 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Max Scherer's work include Smoking Behavior and Cessation (16 papers), Metabolomics and Mass Spectrometry Studies (14 papers) and Carcinogens and Genotoxicity Assessment (14 papers). Max Scherer is often cited by papers focused on Smoking Behavior and Cessation (16 papers), Metabolomics and Mass Spectrometry Studies (14 papers) and Carcinogens and Genotoxicity Assessment (14 papers). Max Scherer collaborates with scholars based in Germany, Switzerland and United States. Max Scherer's co-authors include Gerhard Liebisch, Gerd Schmitz, Gerhard Scherer, Nikola Pluym, Josef Ecker, Carsten Gnewuch, François‐Pierre Martin, Ivan Montoliu, Sebastiano Collino and Serge Rezzi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Chemistry.

In The Last Decade

Max Scherer

71 papers receiving 2.1k citations

Peers

Countries citing papers authored by Max Scherer

Since Specialization

Citations

This map shows the geographic impact of Max Scherer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Scherer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Scherer more than expected).

Fields of papers citing papers by Max Scherer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Scherer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Scherer. The network helps show where Max Scherer may publish in the future.

Co-authorship network of co-authors of Max Scherer

This figure shows the co-authorship network connecting the top 25 collaborators of Max Scherer. A scholar is included among the top collaborators of Max Scherer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Scherer. Max Scherer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessing the exposure to the UV filter DHHB in urine samples from the German Environmental Specimen Bank (2000–2021): Evaluating the impact of a potential impurity of di-n-hexyl phthalate in DHHB 2025 ·International Journal of Hygiene and Environmental Health ·Max Scherer, Gerhard Scherer, Kirsten Riedel, Holger M. Koch, (unknown), Aline Murawski, (unknown), Till Weber, Nikola Pluym, Marike Kolossa‐Gehring	2
2	Protocol for the “magnitude of cigarette substitution after initiation of e-cigarettes and its impact on biomarkers of exposure and potential harm in dual users” (MAGNIFICAT) study 2024 ·Frontiers in Public Health ·Riccardo Polosa, Nikola Pluym, Max Scherer, Jonathan Belsey, Christopher Russell, Pasquale Caponnetto, (unknown), Davide Campagna	1
3	Development of an LC-HRMS non-targeted method for comprehensive profiling of the exposome of nicotine and tobacco product users – A showcase for cigarette smokers 2024 ·Journal of Chromatography B ·(unknown), (unknown), Gerhard Scherer, Max Scherer, Nikola Pluym	1
4	External quality assurance schemes (EQUASs) and interlaboratory comparison investigations (ICIs) for the human biomonitoring of aromatic amines in urine as part of the quality assurance programme under HBM4EU 2024 ·Analytical Methods ·Stefanie Nübler, (unknown), (unknown), Johannes Müller, (unknown), Nikola Pluym, Max Scherer, Gerhard Scherer, Marta Esteban, Argelia Castaño, Hans Mol, Holger M. Koch, Jean‐Philippe Antignac, Jana Hajšlová, Katrin Vorkamp, Thomas Göen	0
5	Identification of Specific Hemoglobin Adduct Patterns in Users of Different Tobacco/nicotine Products by Nontargeted GC–MS/MS Analysis 2024 ·Chemical Research in Toxicology ·(unknown), (unknown), Gerhard Scherer, Max Scherer, Nikola Pluym	0
6	A comprehensive non-targeted approach for the analysis of biomarkers in exhaled breath across different nicotine product categories 2024 ·Journal of Chromatography A ·(unknown), Filip Šibul, (unknown), Gerhard Scherer, Nikola Pluym, Max Scherer	0
7	A sensitive GC–MS/MS method for the quantification of benzo[a]pyrene tetrol in urine 2024 ·Analytical and Bioanalytical Chemistry ·(unknown), (unknown), Nikola Pluym, Gerhard Scherer, Max Scherer	2
8	External Quality Assurance Schemes (EQUASs) and Inter-laboratory Comparison Investigations (ICIs) for human biomonitoring of polycyclic aromatic hydrocarbon (PAH) biomarkers in urine as part of the quality assurance programme under HBM4EU 2023 ·International Journal of Hygiene and Environmental Health ·Stefanie Nübler, Marta Esteban, Argelia Castaño, Hans Mol, Johannes Müller, (unknown), (unknown), Jana Hajšlová, Jana Pulkrábová, Darina Dvořáková, Kateřina Urbancová, Holger M. Koch, Jean‐Philippe Antignac, Amrit Kaur Sakhi, Katrin Vorkamp, (unknown), Max Scherer, Thomas Göen	6
9	Time trend of exposure to secondhand tobacco smoke and polycyclic aromatic hydrocarbons between 1995 and 2019 in Germany – Showcases for successful European legislation 2022 ·Environmental Research ·(unknown), Max Scherer, Gerhard Scherer, Nikola Pluym, Till Weber, Marike Kolossa‐Gehring	8
10	Assessment of the Exposure to NNN in the Plasma of Smokeless Tobacco Users 2022 ·Chemical Research in Toxicology ·Nikola Pluym, Gerhard Scherer, Jeffery Edmiston, (unknown), Mohamadi Sarkar, Max Scherer	7
11	Assessment of the Exposure to Tobacco-Specific Nitrosamines and Minor Tobacco Alkaloids in Users of Various Tobacco/Nicotine Products 2022 ·Chemical Research in Toxicology ·Gerhard Scherer, Max Scherer, (unknown), (unknown), Nikola Pluym	20
12	Urinary cotinine and exposure to passive smoke in children and adolescents in Germany – Human biomonitoring results of the German Environmental Survey 2014–2017 (GerES V) 2022 ·Environmental Research ·(unknown), Maria I.H. Schmied-Tobies, Enrico Rucic, Nikola Pluym, Max Scherer, Małgorzata Dębiak, Aline Murawski, Marike Kolossa‐Gehring	5
13	Assessment of the Exposure to Aromatic Amines in Users of Various Tobacco/Nicotine Products 2022 ·ACS Omega ·Gerhard Scherer, Kirsten Riedel, Nikola Pluym, Max Scherer	8
14	Assessment of the potential vaping-related exposure to carbonyls and epoxides using stable isotope-labeled precursors in the e-liquid 2021 ·Archives of Toxicology ·(unknown), Max Scherer, Gerhard Scherer, Mohamadi Sarkar, Jeffery Edmiston, Reinhard Nießner, Nikola Pluym	13
15	A Sensitive LC–MS/MS Method for the Quantification of 3-Hydroxybenzo[a]pyrene in Urine-Exposure Assessment in Smokers and Users of Potentially Reduced-Risk Products 2021 ·Separations ·(unknown), (unknown), Gerhard Scherer, Max Scherer, Nikola Pluym	18
16	Development of a human biomonitoring method for assessing the exposure to ethoxyquin in the general population 2020 ·Archives of Toxicology ·(unknown), Max Scherer, Franz Bracher, Oliver Peschel, Edgar Leibold, Gerhard Scherer, Nikola Pluym	6
17	Benzene metabolite SPMA and acrylamide metabolites AAMA and GAMA in urine of children and adolescents in Germany – human biomonitoring results of the German Environmental Survey 2014–2017 (GerES V) 2020 ·Environmental Research ·Gerda Schwedler, Aline Murawski, Maria I.H. Schmied-Tobies, Enrico Rucic, Max Scherer, Nikola Pluym, Gerhard Scherer, (unknown), Marike Kolossa‐Gehring	23
18	Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled Ingredients 2018 ·Nicotine & Tobacco Research ·(unknown), Max Scherer, Nikola Pluym, Mohamadi Sarkar, Jeffery Edmiston, Reinhard Nießner, Gerhard Scherer	18
19	Analysis of Urinary Eicosanoids by LC–MS/MS Reveals Alterations in the Metabolic Profile after Smoking Cessation 2018 ·Chemical Research in Toxicology ·(unknown), Reinhard Nießner, Max Scherer, Gerhard Scherer, Nikola Pluym	17
20	Metabolomic Fingerprinting in Various Body Fluids of a Diet-Controlled Clinical Smoking Cessation Study Using a Validated GC-TOF-MS Metabolomics Platform 2017 ·Journal of Proteome Research ·(unknown), Reinhard Nießner, Daniel Mueller, Max Scherer, Gerhard Scherer, Nikola Pluym	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact